Results for tag: "Cabozantinib"

Cabozantinib is a type of drug used to treat advanced thyroid cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking certain proteins that help cancer cells grow and spread. It is used in combination with other treatments, such as radioactive iodine therapy, to help slow the progression of the disease. Cabozantinib has been approved by the US Food and Drug Administration (FDA) for the treatment of advanced thyroid cancer in adults. It is also being studied for use in other types of cancer, such as kidney and liver cancer. Cabozantinib is marketed by several pharmaceutical companies, including Exelixis, Inc., Bristol-Myers Squibb, and Novartis. It is available in both tablet and capsule form. The cost of cabozantinib varies depending on the dosage and the manufacturer. In the cabozantinib market, Exelixis, Inc. is the leading manufacturer, followed by Bristol-Myers Squibb and Novartis. Other companies in the market include Pfizer, AstraZeneca, and Merck. Show Less Read more